Wont Transemi Sustained-Release Tablet

Adult dose

For initial dosage, it is recommended to administer 2 tablets, with subsequent dosing intervals of at least 12 hours apart, not to exceed 8 tablets per day. Avoid using this medication for an extended period unnecessarily, and if prolonged use is essential due to the nature and severity of the illness, regular monitoring should be conducted to confirm the continuation of this medication. For elderly patients, administer the usual adult dosage, but for those aged 75 years and older, dose adjustments are necessary.

This medication may put stress on the liver; therefore, those who regularly consume more than three drinks a day must consult a doctor or pharmacist before taking it. If severe rashes or allergic reactions such as hives occur during the course of taking this medication, stop taking it immediately and inform medical personnel. One of the ingredients in this medication, tramadol, may increase the risk of seizures; therefore, patients with a history of seizures or those at risk for seizures should take it with caution. Taking tramadol with certain antidepressants or other central nervous system depressants may increase the risk of seizures or serious side effects, so consult a physician. In patients with severe respiratory diseases, this medication may suppress breathing, and should be administered in a monitored environment if necessary. Caution is required when taking this medication in conjunction with alcohol or benzodiazepine medications, as it may lead to severe drowsiness, respiratory depression, or coma. Patients with head injuries or elevated intracranial pressure should take this medication cautiously, as symptoms may worsen. This medication can cause physical and psychological dependence; therefore, long-term use should be carefully monitored for dependence and abuse risks. Patients with impaired liver function may face a risk of liver damage when taking this medication, so they must consult healthcare providers before taking it. Particularly, patients genetically predisposed to rapid metabolism of this medication may have an increased risk of side effects like respiratory depression, thus requiring dose adjustment and close monitoring. This medication should not be administered to children under 12 years old or adolescents under 18 years old who have undergone tonsillectomy and adenoidectomy. Elderly patients or those with decreased kidney or liver function may have an increased risk of side effects from this medication, so caution is advised. Pregnant or breastfeeding women should consult a physician before taking this medication, particularly during breastfeeding, as it may transfer to breast milk and pose risks to the baby. This medication may cause drowsiness or dizziness, so caution is needed when driving or operating machinery. In case of overdose, serious respiratory depression or liver damage may occur, so prescribed dosages must be adhered to, and immediate emergency measures should be taken in case of overdose. Abruptly stopping this medication may cause withdrawal symptoms, so it should be gradually reduced under medical supervision when discontinuing.

Serious side effects

Hives, severe swelling (edema), cold sweat, severe allergic reactions, severe rashes with high fever, blisters, peeling skin, pain in mucous membranes of the mouth/eyes, severe skin reactions, shortness of breath or difficulty breathing, asthma attacks, respiratory anomalies accompanied by coughing and fever, difficulty breathing, yellowing of the skin or eyes (jaundice), liver abnormalities (jaundice), sudden and severe headaches, lightning headaches, seizures, altered consciousness, visual disturbances

Mild side effects

• Weakness
• fatigue
• flushing
• rigidity
• fainting
• withdrawal symptoms
• hypertension
• worsening of hypertension
• hypotension
• arrhythmia

This medication should be stored in a sealed container to protect it from air and moisture. It is recommended to maintain storage temperatures between 1 degree Celsius and 30 degrees Celsius.

Appearance

Pale yellow round film-coated sustained-release tablet

Package unit

30 tablets/bottle, 100 tablets/bottle